title: Re: damien pouessel, stéphane culine. High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor. Eur urol 2008;53:376-81.
authors.forename: Camillo
authors.initials: C
authors.lastname: Porta
authors.forename: Ilaria
authors.initials: I
authors.lastname: Imarisio
authors.forename: Chiara
authors.initials: C
authors.lastname: Paglino
mesh_terms: D001557:Benzenesulfonates / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000150:complications / Q000188:drug therapy / Q000556:secondary*; D002292:Carcinoma, Renal Cell / Q000150:complications / Q000188:drug therapy / Q000556:secondary*; D002543:Cerebral Hemorrhage / Q000453:epidemiology* / Q000209:etiology; D005602:France / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007680:Kidney Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000201:enzymology; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000187:drug effects*; D012307:Risk Factors; D000077157:Sorafenib; D016896:Treatment Outcome
chemical_list: D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib; D040262:Receptors, Vascular Endothelial Growth Factor